Torrent Pharma Brand Guidelines: Trinity Laboratories 1959, Ahmedabad & the JB Chemicals Merger

U. N. Mehta’s company, renamed in 1971.

Torrent Pharma began in 1959 as Trinity Laboratories, set up by U. N. Mehta, English Wikipedia says, and was renamed Torrent Pharmaceuticals in 1971. It trades as Torrent Pharma. In January 2026 Medical Dialogues described it as headquartered in Ahmedabad, Gujarat, and listed on the Bombay Stock Exchange and the National Stock Exchange of India.

The drug maker is one part of the Torrent Group, an Ahmedabad conglomerate founded by Uttambhai Nathalal Mehta and now run by his sons, Sudhir and Samir Mehta, according to English Wikipedia, which names gas, pharmaceuticals and power as the group’s core businesses. Its sister companies include Torrent Power, which grew from the purchase of two old city utilities, the Ahmedabad Electricity Company and the Surat Electricity Company, completed in 1997, and Torrent Gas, a city-gas distributor. In 2025, the same article says, the group bought a majority stake in the Indian Premier League cricket team Gujarat Titans.

The power side of the group has its own landmarks. English Wikipedia records that Torrent Power was formed in 2006 by merging three group power companies, that in December 2006 it signed what the article calls the country’s first electricity distribution franchise agreement, for Bhiwandi in Maharashtra, and that the group’s cable business, Torrent Cables, was merged into Torrent Power with effect from 1 April 2014.

English Wikipedia describes Torrent Pharma as active in more than 40 countries, with more than 2,000 product registrations. It names its main therapy areas as cardiovascular, central nervous system, gastro-intestinal, diabetes, anti-infective and pain management, with smaller positions in nephrology, oncology, gynaecology, respiratory medicine and paediatrics.

Growth through deals.

Much of Torrent’s growth has come through partnerships and purchases, English Wikipedia records. In 1997 it formed a 50:50 joint venture with Sanofi, called Sanofi Torrent, to sell Torrent’s products, and it left the venture in 2002 by selling its stake to Sanofi. In 2005 it bought Heumann Pharma Generics, a German generics company then owned by Pfizer.

In India it added businesses in three steps, according to the same article: in 2013 the India formulations business of Elder Pharmaceuticals, in 2017 the domestic business of Unichem Laboratories, and in 2022 the skincare maker Curatio Healthcare.

Its most recent deal is J.B. Chemicals & Pharmaceuticals. Under a share purchase agreement dated 29 June 2025 with Tau Investment Holdings, J.B. Chemicals’ promoter, Torrent agreed to buy a controlling stake, and it completed that purchase on 21 January 2026, when it became J.B. Chemicals’ promoter with 46.39 percent of the shares on a fully diluted basis, Medical Dialogues reported on 23 January 2026. It followed a series of disclosures Torrent made to the stock exchanges between June and December 2025, and alongside the promoter’s shares Torrent bought a small number of further shares through an open offer, the report said. Torrent said the acquisition aligned with its long-term strategic objectives and strengthened its presence across key therapy areas.

A full merger followed. The boards of both companies had approved a scheme to merge J.B. Chemicals into Torrent on 29 June 2025, with the appointed date set at 21 January 2026; shareholders approved it at meetings on 28 April 2026, with 99.02 percent of J.B. Chemicals’ public shareholders voting in favour; and the Ahmedabad bench of the National Company Law Tribunal sanctioned the amalgamation on 6 July 2026, LiveLaw reported on 9 July 2026. The companies told the tribunal the merger would consolidate operations, expand product offerings and bring economies of scale. The tribunal noted that no objections had been raised against the scheme, and Torrent gave an undertaking to take responsibility for any tax liabilities of J.B. Chemicals arising after the merger, LiveLaw reported; a question from the regional director over fees and stamp duty was answered with Torrent’s statement that they would be paid as required.

Design and documentation.

India’s drug makers are spread across several states, and some regions have become clusters. English Wikipedia’s article on the pharmaceutical industry in Gujarat calls Ahmedabad and Vadodara the state’s pharmaceutical hubs and records that the state government declared Gujarat a “pharma hub” in 2000; Torrent Pharma’s plants at Chhatral and Dahej are in the same state. Glenmark’s August 2026 factsheet lists formulation plants in Goa, Sikkim, Madhya Pradesh, Himachal Pradesh and Maharashtra, as well as in Argentina, the United States and the Czech Republic.

Many of the companies in this guide began as family firms and still carry their founders’ stories. Glenmark’s name, English Wikipedia says, was made from the names of its founder’s two sons; Torrent Pharma started in 1959 as Trinity Laboratories and belongs to a group that also runs power and gas businesses. Where a company’s history rests only on its own website, this guide says so.

The industry has its own meeting places. CPHI India, the Informa trade fair that bills itself as “the heart of South Asia’s pharma,” runs from 23 to 26 November 2026 at the IICC in Delhi, alongside the PMEC India machinery show at Greater Noida, according to its website. DCAT Week, which calls itself “the premier event for the global bio/pharmaceutical business ecosystem,” is next held in New York City from 15 to 18 March 2027.

This guide looks at how each company presents itself — in plant photographs, laboratory imagery, packs, founder portraits and corporate colours — and sets out what can be checked about each one: who founded it, who owns it and where it says its medicines are made, marking clearly what rests only on the company’s own word.

An Ahmedabad name in a Gujarat industry.

English Wikipedia’s Torrent Group article lists four Torrent Pharma manufacturing plants — at Chhatral and Dahej in Gujarat, at Baddi in Himachal Pradesh and at Gangtok in Sikkim — and a research centre at Bhat, near Ahmedabad.

Those sites sit in one of India’s main drug-making states. English Wikipedia’s article on the pharmaceutical industry in Gujarat calls Ahmedabad and Vadodara the state’s pharmaceutical hubs, dates Alembic, in Vadodara, to 1907, places Cadila Laboratories among the firms founded in the 1940s and 1950s, and records that the state government declared Gujarat a “pharma hub” in 2000. Torrent is one of the large companies the article names, alongside Zydus Lifesciences, Intas and Sun Pharma, and it records that Torrent received US FDA approval for its manufacturing facilities in 2003.

The Torrent name is shared across the group’s pharmaceutical, power and gas companies, according to English Wikipedia, so the drug maker carries a family group’s name rather than one of its own.

For a design guide, Torrent Pharma shows how a single family-group name can carry a drug maker built largely through acquisitions. Compare Zydus, which began as Cadila in 1952, and Glenmark, the Mumbai drug maker named after its founder’s sons. For this guide we use a deep teal and an ochre with a serif, an unofficial interpretation; no product or logo is reproduced.

Keep Torrent Pharma’s identity on hand — save it to a board in the Made Good inspiration library.